1 – 10 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Intracranial hemorrhage before start of prophylaxis in children with hemophilia : incidence, timing, and potential for prevention
- Contribution to journal › Article
-
Mark
Risk of infections in multiple myeloma. A population-based study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
- Contribution to journal › Article
-
Mark
Trends in mortality rate after cancer-related thrombosis give hope for the future
- Contribution to journal › Debate/Note/Editorial
-
Mark
H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance
- Contribution to journal › Letter
-
Mark
Response to Comment on : Multimorbidity, comorbidity, frailty, and venous thromboembolism
- Contribution to journal › Letter
- 2024
-
Mark
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemia
- Contribution to journal › Letter
-
Mark
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma : a 10-year follow-up
- Contribution to journal › Letter
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
- Contribution to journal › Article
-
Mark
PVT1 interacts with polycomb repressive complex 2 to suppress genomic regions with pro-apoptotic and tumour suppressor functions in multiple myeloma
- Contribution to journal › Article
-
Mark
Multimorbidity, comorbidity, frailty, and venous thromboembolism
- Contribution to journal › Scientific review
